Details for Patent: 7,981,938
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,981,938 protect, and when does it expire?
Patent 7,981,938 protects COLCRYS and is included in one NDA.
Summary for Patent: 7,981,938
Title: | Colchicine compositions and methods |
Abstract: | Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. |
Inventor(s): | Davis; Matthew W. (Erwinna, PA) |
Assignee: | Mutual Pharmaceutical Company, Inc. (Philadelphia, PA) |
Application Number: | 12/687,406 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,981,938 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,981,938
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | COLCRYS | colchicine | TABLET;ORAL | 022352-001 | Jul 29, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | A METHOD FOR TREATMENT OF GOUT FLARES DURING PROPHYLAXIS | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |